Dr. Scott Gottlieb Visits Eagle’s New Facility
Eagle President and CEO Dr. Ross Caputo took the opportunity to share our mission of ensuring the safety and quality of compounded preparations through science-based solutions. Dr. Gottlieb was also given an overview of Eagle’s aim to impact the compounding industry by promoting practices that both meet and exceed regulatory expectations.
Gottlieb served as the 23rd Commissioner of the FDA from May 2017 to April 2019. He is a physician, medical policy expert, and public health advocate who previously served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs, and before that, as a senior advisor to the FDA Commissioner (1).
- EAGLE Seminar Conference 2021|🦅EVENT NOTICE - September 9, 2021
- Happy Labor Day Everyone – Eagle will be closed on 09/06 - September 1, 2021
- Environmental Monitoring Analyses: Early Warning Opportunities for Sterile Compounders - July 23, 2021